Need Help?
Contact Us


Peripheral Thrombectomy Catheter

DVT Thrombectomy

ZelanteDVT Catheter

The AngioJet ZelanteDVT thrombectomy catheter is specifically designed to treat deep vein thrombosis (DVT) in large-diameter upper and lower peripheral veins ≥ 6 mm. ZelanteDVT is the most powerful thrombectomy catheter in the market-leading AngioJet portfolio.

The ZelanteDVT catheter makes it possible to quickly remove large thrombus burden in veins and restore blood flow, giving you the power to dominate DVTs.

  • Four times the thrombus-removal power of Solent™ Omni and Solent Proxi catheters*
  • Single inflow window for torqueable and directional thrombectomy power
  • Power Pulse™ enabled for infusion of physician-specified fluids, including thrombolytic agents
  • Inflow window indicator band


Solent Omni and Proxi Catheters

The Solent Omni and Proxi catheters provide the power and flexibility to remove thrombus in veins ≥ 3 mm.  Power Pulse Delivery can infuse lytic into the clot. Contrast injection capability and guidewire exchange increase treatment efficiencies.


Venous Catheter Specifications

  ZelanteDVT Solent Omni Solent Proxi
System Compatibility Ultra Ultra Ultra
Vessel Diameter ≥ 6 mm 3 mm 3 mm
Working Length 105 cm 120 cm 90 cm
Shaft Diameter 8 F 6 F 6 F
Double Marker Band 15 mm N/A N/A
Guidewire Compatibility 0.035” 0.035" 0.035"
Sheath Compatibility 8 F 6 F 6 F


The Need to More Efficiently Treat Large Vein Thrombosis


Expert Panel Discussion on DVT

AV Access Thrombectomy

Thrombus narrowing or restricting flow within AV access fistulas and grafts can prevent a patient from undergoing life supportive dialysis treatment. 

Used for thrombectomy of both synthetic grafts and natural fistulae, the AngioJet System utilizes powerful Cross-Stream technology to remove thrombotic materials from the dialysis access conduit with minimal vessel wall trauma, potentially decreasing the risk for future thrombotic events. 

Catheters with AV access indication include: AVX, Solent Proxi and Solent Omni 


Clinical Data

The AngioJet™ Thrombectomy System provides the power and flexibility to remove venous thrombus and restore flow in the most challenging of DVT cases.

For deep vein thrombosis cases, the PEARL Registry data demonstrated

  • 34% of patients were treated in a single session
  • 75% of procedures were completed in < 24 hours
  • Less total lytic dose for treating DVT when using PowerPulse/Rapid Lysis (with/without CDT) versus CDT alone.

Learn more about the PEARL Registry

AngioJet ZelanteDVT was not studied in the PEARL Registry. Presented by Dr. Mark Garcia at CIRSE 2013; Final PEARL Data Aug 2013


What’s New

Find DVT education, expert opinions and resources to raise awareness about interventional DVT treatment options.